Traditional analog front-ends for biomedical signal acquisitions operate at very low frequencies (Hz-range) and are severely affected by flicker and environmental noise, which degrade the quality of low-frequency signals, thereby reducing the signal-to-noise ratio (SNR). While offering advantages, the increasingly common use of microelectrodes poses challenges due to their low-frequency high impedance, which is comparable to the one of the front-end, thus creating additional difficulties in signal acquisition. To tackle the challenges of in-vitro low-frequency biosignal acquisition, this letter proposes a novel methodology based on the upconversion of low-frequency biosignals to a higher frequency band by a Schottky diode immersed in a solution. This letter aims to demonstrate the feasibility of the new sensory method by translating in frequency the information of a sinewave stimulus representing a biological signal. Experimental results showed a conversion loss of 11.11 dB and demonstrated the upconverted signal propagation in the solution, measuring an intermodulation power above the noise floor, from <tex-math notation="LaTeX">$-$</tex-math> 87.04 to <tex-math notation="LaTeX">$-$</tex-math> 104.13 dBm. The proposed method provides a better signal-to-noise ratio than the traditional acquisition method, estimating an improvement of 8.99 dB.
No takes yet. Share an insight, caveat, or question.
Bontempi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: